References
- Mazzaferro P., Pulvirenti A., Coppa J. Neuro-endocrine tumours metastatic to the liver: how to select patients for liver transplantation. J Hepatol, 2007, 47: 460–466.
- LetreutY. P., Grégoire E., Belghiti J. et al. Predictors of long-term survival after liver transplantation for metastatic endocrine tumours: an 85-case French multi-centric report. Am J Transplant, 2008, 8: 1205–1213.
- Que F. G., Nagorney D. M., Batts K. P. et al. Hepatic resection for metastatic neuro-endocrine carcinomas. Am J Surg, 1995, 10: 3643.
- Pascher A., Klupp J., Neuhaus P. Transplantation in the management of metastatic endocrine tumours. Best pract res clin gastro-enterol, 2005, 19: 637–648.
- Lang H., Schlitt H. J., Flemming P. et al. Total hepatectomy and liver transplantation for metastatic neuro-endocrine tumours of the pancreas-a single centre experience with ten patients. Langenbecks Arch Surg, 1999, 384: 370–377.
- Lehnert T. Liver transplantation for metastatic neuro-endocrine carcinoma: An analysis of 103 patients. Transplantation, 1998, 66: 1307–1312.
- Rosenau J., Bahr M., Von Wasielewski K. et al. Ki67, E-cadherin and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuro-endocrine tumours. Transplantation, 2002, 73: 386–394.